Results 221 to 230 of about 295,380 (280)

Comparison of epcoritamab, lenalidomide, and rituximab versus usual care in relapsed/refractory follicular lymphoma. [PDF]

Oncoimmunology
Falchi L, Hutchings M, Tybor D, Yu J, Alshreef A, Wang A, Sail K, Ding Z, Mutebi A, Patah P, Kishore N, Rana A, Favaro E, Linton K.   +13 more
europepmc   +1 more source

Paraneoplastic pemphigus associated with follicular lymphoma and myasthenia gravis: Efficacy of a lenalidomide-rituximab-corticosteroid regimen. [PDF]

JAAD Case Rep
Shen Y, Wang Q, Xu C, Zhu W, Zhu H, Pan M, Wang J.   +6 more
europepmc   +1 more source

Unmasking a Composite Lymphoma: Follicular Lymphoma Emerging After Bispecific Antibody Treatment of Marginal Zone Lymphoma. [PDF]

EJHaem
Orosco-Ttamina AL, Zhou J, Biondo J, Hossain F, Viswanatha D, Greipp PT, Lewis N, Munoz J.   +7 more
europepmc   +1 more source

Mosunetuzumab for relapsed follicular lymphoma presenting with chylothorax: A case report and literature review. [PDF]

J Clin Exp Hematop
Naganuma K, Hirata K, Arai Y, Tezuka S, Matsunaga T, Kawada T, Sakata N, Takahashi Y, Yamashita T, Momose S, Higashi M, Tabayashi T.   +11 more
europepmc   +1 more source

Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop. [PDF]

Blood Adv
Merryman R, Rutherford SC, Ansell S, Armand P, Leonard JP, Nastoupil L, Smith SM, Timmerman J, Zelenetz AD, Gutierrez M, Béguelin W, Casulo C, Cerhan J, Green M, Kahl B, Kridel R, Link B, Maurer MJ, Nadel B, Radtke AJ, Luttwak E, Salles G, Sehn L, Pasqualucci L, LaCasce AS.   +24 more
europepmc   +1 more source

Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma. [PDF]

Hemasphere
Belada D, Gardner FP, de Oliveira AC, Sancho JM, Lomaia E, Wright D, Turgut M, Martynova E, Lázár Z, Anz B, Wang MC, Legiec W, Opat S, Pailden J, Peltier HM, Marturano E, Dean JP, Flinn IW.   +17 more
europepmc   +1 more source

Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma. [PDF]

Cancers (Basel)
Lafuente M, Diez-Feijóo R, García-Recio M, Garcia-Gisbert N, Fernández-Rodríguez MC, Longarón R, Ji J, Tazon-Vega B, Pinzón S, Fernández-Ibarrondo L, Sánchez-González B, Camacho L, Gibert J, Gutierrez A, Bellosillo B, Salar A.   +15 more
europepmc   +1 more source

Utility of MEF2B immunohistochemistry in distinguishing follicular lymphoma and marginal zone lymphoma in diagnostically challenging cases. [PDF]

J Hematop
Dalland JC, Oyedeji OS, Viswanatha DS, Artymiuk CJ, Howard MT, King RL.   +5 more
europepmc   +1 more source

The management of follicular lymphoma

Annals of Oncology, 1991
openaire   +2 more sources